Fluorodopa F 18 Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: (18F)FDOPA, 18F-DOPA, 18F-FDOPA, 3-(2-Fluoro-(sup 18)F-4,5-dihydroxyphenyl)-L-alanine, 6-(18F)Fluoro-L-DOPA, 6-[18F]fluorolevodopa (U.S. Pharmacopeia), FLUORODOPA F-18, Fluorine F 18 Fluorodopa, Fluorine-18-fluoro-L-DOPA, Fluorodopa (18F), Fluorodopa 18F (International Non-Proprietary Name), Fluorodopa F 18 (CAS Number 75290-51-6), L-6-(18F)Fluoro-DOPA

Filter by location:

Rochester, Minnesota1 trial

Sequential Treatments or Combinations Including Dasatinib, Quercetin, Fisetin and/or Temozolomide for the Treatment of Previously Treated Glioma With Residual Disease

Mayo Clinic in Rochester

Early 1

Fort Worth, Texas1 trial

Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma

Cook Children's Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.